IP Library Granted Patent US 7,196,162
Granted Patent B2
US 7,196,162 · App. 11/031,488 · Granted Mar 27, 2007

Anti-aging and wound healing compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,196,162
App. No.
11/031,488
Granted
Mar 27, 2007
Kind
B2
Abstract

The invention provides inhibitors of matrix metalloproteinases that are useful for encouraging the development of healthy skin and for treating wounds. The inhibitors are peptides having sequences related to cleavage regions of the proenzyme forms of matrix metalloproteinases. The peptide inhibitors of the invention can be formulated into therapeutic compositions, lotions, creams, skin covering and wound dressings that facilitate healing and healthy skin development, discourage scarring and wrinkling and ameliorate the effects of healing.

Claims (8)

1. An isolated peptide consisting of SEQ ID NO:2, SEQ ID NO:6 or SEQ ID NO:7, wherein the peptide inhibits matrix metalloproteinase-2.

2. A composition that comprises a therapeutically effective amount of an isolated peptide consisting of SEQ ID NO:2, SEQ ID NO:6, or SEQ ID NO:7, and a pharmaceutically acceptable carrier.

3. The composition of claim 2 wherein the peptide INHIBITS MATRIX METALLOPROTEINASE activity of any one of matrix metalloproteinase-1, matrix metalloproteinase-2, matrix metalloproteinase-3, matrix metalloproteinase-4, matrix metalloproteinase-4, matrix metalloproteinase-5, matrix metalloproteinase-6, matrix metalloproteinase-7, matrix metalloproteinase-8, and matrix metalloproteinase-9, matrix metalloproteinase- 10, matrix metalloproteinase-11, or matrix metalloproteinase-12.

4. A wound dressing that comprises an isolated peptide consisting of SEQ ID NO:2, SEQ ID NO:6, or SEQ ID NO:7, wherein the peptide INHIBITS a matrix metalloproteinase.

5. The wound dressing of claim 4 , wherein the dressing promotes wound healing, treats scarring, improves skin tone, reduces wrinkling, or stimulates the development of a smooth, healthy skin.

6. A lotion that comprises an isolated peptide consisting of SEQ ID NO:2, SEQ ID NO:6, or SEQ ID NO:7, wherein the peptide INHIBITS a matrix metalloproteinase or promote the growth of fibroblasts.

7. A method for promoting healthy skin development that comprises administering a therapeutically effective amount of an isolated peptide consisting of SEQ ID NO:2, SEQ ID NO:6 or SEQ ID NO:7;

wherein the peptide is capable of inhibiting the activity of a matrix metalloproteinase and of promoting the growth of fibroblasts.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jun 30, 2022
From: CITIBANK, N.A.
To: AVENT, INC.; AVANOS MEDICAL SALES, LLC
Reel/Frame 060557/0062 →
SECURITY INTEREST Recorded Jun 24, 2022
From: AVENT, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060441/0445 →
INTELLECTUAL PROPERTY SECURITY INTEREST ASSIGNMENT AGREEMENT Recorded Jan 23, 2019
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: CITIBANK, N.A.
Reel/Frame 048173/0137 →
SECURITY INTEREST Recorded Apr 6, 2015
From: AVENT, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 035375/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2015
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: AVENT, INC.
Reel/Frame 034754/0424 →